BioArctic (Sweden) Analysis
| BIOA-B Stock | SEK 194.40 5.30 2.80% |
BioArctic AB is overvalued with Real Value of 152.33 and Hype Value of 194.4. The main objective of BioArctic stock analysis is to determine its intrinsic value, which is an estimate of what BioArctic AB is worth, separate from its market price. There are two main types of BioArctic's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect BioArctic's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of BioArctic's stock to identify patterns and trends that may indicate its future price movements.
The BioArctic stock is traded in Sweden on Stockholm Exchange, with the market opening at 09:00:00 and closing at 17:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Sweden. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and BioArctic's ongoing operational relationships across important fundamental and technical indicators.
BioArctic |
BioArctic Stock Analysis Notes
About 48.0% of the company shares are held by company insiders. The company last dividend was issued on the 10th of May 2019. BioArctic AB , a research intensive biopharmaceutical company, develops disease modifying treatments and diagnostics for neurodegenerative diseases in Sweden. BioArctic AB was founded in 1992 and is headquartered in Stockholm, Sweden. BioArctic is traded on Stockholm Stock Exchange in Sweden. For more info on BioArctic AB please contact the company at 46 86 95 69 30 or go to https://www.bioarctic.se.BioArctic AB Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. BioArctic's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding BioArctic AB or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| BioArctic AB had very high historical volatility over the last 90 days | |
| The company reported the revenue of 23.15 M. Net Loss for the year was (119.79 M) with profit before overhead, payroll, taxes, and interest of 155.53 M. | |
| BioArctic AB has accumulated about 848.4 M in cash with (140.46 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 13.84. | |
| Roughly 48.0% of the company shares are held by company insiders |
BioArctic Market Capitalization
The company currently falls under 'Large-Cap' category with a current market capitalization of 26.34 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioArctic's market, we take the total number of its shares issued and multiply it by BioArctic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.BioArctic Profitablity
BioArctic's profitability indicators refer to fundamental financial ratios that showcase BioArctic's ability to generate income relative to its revenue or operating costs. If, let's say, BioArctic is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, BioArctic's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of BioArctic's profitability requires more research than a typical breakdown of BioArctic's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.03) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.03. Technical Drivers
As of the 27th of November, BioArctic shows the Risk Adjusted Performance of 0.0631, mean deviation of 2.73, and Downside Deviation of 3.2. BioArctic AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.BioArctic AB Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. BioArctic middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for BioArctic AB. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
BioArctic Outstanding Bonds
BioArctic issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioArctic AB uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioArctic bonds can be classified according to their maturity, which is the date when BioArctic AB has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
BioArctic Predictive Daily Indicators
BioArctic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioArctic stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 11596.28 | |||
| Daily Balance Of Power | 0.6235 | |||
| Rate Of Daily Change | 1.03 | |||
| Day Median Price | 193.25 | |||
| Day Typical Price | 193.63 | |||
| Price Action Indicator | 3.8 | |||
| Period Momentum Indicator | 5.3 |
BioArctic Forecast Models
BioArctic's time-series forecasting models are one of many BioArctic's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioArctic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About BioArctic Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how BioArctic prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BioArctic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BioArctic. By using and applying BioArctic Stock analysis, traders can create a robust methodology for identifying BioArctic entry and exit points for their positions.
BioArctic AB , a research intensive biopharmaceutical company, develops disease modifying treatments and diagnostics for neurodegenerative diseases in Sweden. BioArctic AB was founded in 1992 and is headquartered in Stockholm, Sweden. BioArctic is traded on Stockholm Stock Exchange in Sweden.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding BioArctic to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Performance Analysis Now
Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation |
| All Next | Launch Module |
Complementary Tools for BioArctic Stock analysis
When running BioArctic's price analysis, check to measure BioArctic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioArctic is operating at the current time. Most of BioArctic's value examination focuses on studying past and present price action to predict the probability of BioArctic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioArctic's price. Additionally, you may evaluate how the addition of BioArctic to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |